Parkinson’s
A novel drug molecule could potentially lead to new treatments to prevent Parkinson’s disease in younger patients, according to new research. While Parkinson’s symptoms — slowed movements, tremors and balance problems — often appear in people in their 60s, five to 10 per cent of people are diagnosed before they turn 40. A new study [...]
An NHS England programme announced this week will help to protect people with Parkinson's from potential harm associated with poor access to time critical medication, campaigners say. NHS England has committed to a three year Medicines Safety Improvement Programme focused on time critical medication. The move follows a long campaign from charity Parkinson's UK over [...]
Researchers have developed a new method for detecting protein aggregation in cells – a hallmark of Parkinson's disease. The technology can enable diagnosis up to 20 years before the first motor symptoms appear, facilitating treatment or even prevention of the severe disease which is currently incurable. The novel approach is based on super-resolution microscopy combined [...]
Phoenix 681 FC - a team of UK football players with Parkinson's Disease - is heading to the Ray Kennedy Cup to raise awareness of the condition. The Ray Kennedy Weekend is an international football tournament for people with Parkinson's Disease. Taking place in Norway this September. The Ray Kennedy Cup was established in memory [...]
Vandria SA has closing of its Series A financing bringing the final amount raised to date to $30.7 million. Vandria, which is developing small molecule mitophagy inducers against a novel target to rejuvenate cells and treat age-related and chronic diseases, has stated that the funds will go towards progressing its Mitophagy Inducer VNA-318 into clinical [...]
An implanted device regulated by the body’s brain activity could provide continual and improved treatment for the symptoms of Parkinson’s disease (PD) in certain people with the disorder. This type of treatment, called adaptive deep brain stimulation (aDBS), is an improvement on a technique that has been used for PD and other brain disorders for [...]
Parkinson's UK has confirmed it is investing £1.6m through its Virtual Biotech programme to drive the development of a promising molecule which has the potential to become a drug that slows or stops Parkinson’s. Parkinson's UK is partnering with US-based company Acurex Biosciences to support the final stages of testing and development of their molecule, [...]
Researchers at the University of Minnesota, have developed a new visual diagnostic technique that can be used to advance early detection for neurodegenerative diseases like Parkinson's disease. Named Cap-QuIC (Capillary-enhanced Quaking-Induced Conversion), researchers will now be able to distinguish infected samples with the naked eye, which makes testing more accessible and cost-effective. This new method [...]
Genetic variants associated with Parkinson’s disease (PD) are more common than researchers previously believed, new research has revealed. Investigators in the Parkinson’s Foundation-backed PD GENEration study – which reached its goal of 15,000 participants ahead of schedule this spring – found that 13 per cent of participants have a genetic form of PD, which is [...]
Aligning Science Across Parkinson’s (ASAP) has launched a new platform - the ASAP CRN Cloud - a data-sharing tool designed to advance Parkinson’s disease (PD) research by making data easily available to researchers worldwide The platform contains data from a unique human postmortem-derived brain sequencing collection. These include samples from four ASAP Collaborative Research Network (CRN) [...]
